High prevalence of obstructive sleep apnea syndrome in nondialyzed severe chronic renal failure patients

F. Di Marco, S. M. Pizzolato, M. Cozzolino, E. Zambrelli, G. F. Sferrazza Papa, D. Brancaccio, S. Centanni (Milan, Italy)

Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Session: Socio-economic and epidemiological aspects of sleep apnoea
Session type: Thematic Poster Session
Number: 3676
Disease area: Sleep and breathing disorders

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Di Marco, S. M. Pizzolato, M. Cozzolino, E. Zambrelli, G. F. Sferrazza Papa, D. Brancaccio, S. Centanni (Milan, Italy). High prevalence of obstructive sleep apnea syndrome in nondialyzed severe chronic renal failure patients. Eur Respir J 2009; 34: Suppl. 53, 3676

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients.
Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea
Year: 2019

The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009

Chronic respiratory failure in patients with obstructive sleep apnea (OSA)
Source: Eur Respir J 2005; 26: Suppl. 49, 569s
Year: 2005

The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome
Source: Eur Respir J 2002; 20: Suppl. 38, 293s
Year: 2002

Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006

Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018

Clinical-functional characteristics in patients with combination pathology – chronic obstructive pulmonary disease and obstructive sleep apnea-hypopnea syndrome
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Presence of sleep apnea syndrome in the group of severe and very severe COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 198s
Year: 2006

High flow-nasal cannula oxygen treatment in patients with concomitant severe chronic obstructive pulmonary diseases and mild-moderate  sleep apnea  (overlap syndrome).
Source: Virtual Congress 2020 – Advance in treatments for sleep and breathing disorders and long-term adherence
Year: 2020

Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006

Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension
Source: International Congress 2019 – Current perspectives in sleep-disordered breathing
Year: 2019

Unrecognised hypertension in patients screened for obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 40s
Year: 2005

Leukocytosis as a marker of chronic inflammation and early cardiovascular risk in patients with obstructive sleep apnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 593s
Year: 2007

Assessment of the prevalence of obstructive sleep apnea in patients with undiagnosed chronic cough
Source: Annual Congress 2012 - Sleep disorders in internal medicine
Year: 2012


Myocardial alterations in asymptomatic patients with obstructive sleep apnea syndrome
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017


Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism
Source: Sleep and Breathing Conference 2021
Year: 2021